Categories: News

Daw Systems, Inc. ScriptSure Cloud ERX Product Has Been Awarded EHR Vendor White Coat Award for Highest E-Prescribing Accuracy by the Surescripts Network

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

ALBANY, N.Y.–(BUSINESS WIRE)–#eprescribing–Daw Systems, Inc., a leading provider of electronic prescribing software technology, announced that it is a recipient of the 2021 Surescripts White Coat Award for Highest Accuracy. Daw Systems, Inc. core product, ScriptSure Cloud ERX v2.0, incorporates extensive functionality from Surescripts network giving medical professionals the ability to electronically send prescriptions to pharmacies. The Surescripts press release can be found here:

“We are extremely honored to receive this award for our ScriptSure Cloud ERX application. Our company mission is to deliver featured-rich electronic prescribing solutions directly to medical professionals and our technology EHR partners while executing our core competencies: improving the prescribing workflow, increasing patient safety and ensuring compliant prescriptions every time. This award is the embodiment of our team’s efforts and we are all thrilled to receive it. We are thankful to our entire staff and for the support of Surescripts account team that provided input and guidance throughout the year on the path to this award,” said Adam Forman, Chief Operating Officer of Daw Systems, Inc.

“Medical professionals feel the effects in having to rework and resend prescriptions and spend time on support cases for their technology rather than on patient care. Prescription accuracy helps with the efficiency of the entire healthcare system as it relates to prescriptions. For Daw Systems, Inc., incorporating validation and checks to avoid prescription errors and avoiding any prescription issues is among our primary objectives. The White Coat Award is a testament to our staff’s efforts on this front. Accurate prescriptions should be of paramount concern to all industry stakeholders,” said Adam Forman, COO.

About Daw Systems, Inc. (ScriptSure Cloud ERX)

Daw Systems, Inc. develops ScriptSure software enabling all provider specialties and vendor partners with E-Prescribing, medication management functions and medication history reporting. Our ScriptSure E-Prescribing application has been ranked #1 by combining First Databank clinical databases, Surescripts® network connectivity, web-based architecture and the best work flow methods. Accolades include SureScripts White Coat awards, accreditation by EHNAC for Privacy and Security and EPCS. To learn more, visit https://www.dawsystems.com.

Contacts

Media Inquiries
Daw Systems, Inc. (ScriptSure)

Adam Forman, Esq.

Chief Operating Officer

sales@dawsystems.com
866-755-1500

Staff

Recent Posts

Assembly Biosciences Presents Data Highlighting Recurrent Genital Herpes Program at STI & HIV 2025 World Congress and International Herpesvirus Workshop

– Phase 1a clinical data in healthy participants presented for both ABI-5366 and ABI-1179, novel…

2 hours ago

ISS Recommends Shareholders Vote FOR the Merger between Regional Health Properties, Inc. and SunLink Health Systems, Inc.

Atlanta, GA., July 25, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (“Regional”) (OTCBQ: RHEP)…

2 hours ago

PharmAla Issues Q3 Financial Statements

TORONTO, July 25, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”)…

2 hours ago

Calidi announces Reverse Stock Split, expected to begin trading on a 1-for-12 split adjusted basis on August 5, 2025

SAN DIEGO, July 25, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (“Calidi” or the “Company”)…

2 hours ago

Portage Biotech Reports Results for Fiscal Year Ended March 31, 2025

DOVER, Del., July 25, 2025 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (“Portage” or the “Company”)…

2 hours ago

IRADIMED CORPORATION to Hold Second Quarter of 2025 Financial Results Conference Call on August 1, 2025

ORLANDO, Fla., July 25, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the…

2 hours ago